+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmacovigilance and Drug Safety Software - Global Market Trajectory & Analytics

  • ID: 5140073
  • Report
  • September 2020
  • Region: Global
  • 181 pages
  • Global Industry Analysts, Inc
1 of 2
Global Pharmacovigilance and Drug Safety Software Market to Reach $201.8 Million by 2027

Amid the COVID-19 crisis, the global market for Pharmacovigilance and Drug Safety Software estimated at US$143 Million in the year 2020, is projected to reach a revised size of US$201.8 Million by 2027, growing at a CAGR of 5.1% over the analysis period 2020-2027. ADR Reporting, one of the segments analyzed in the report, is projected to record a 4.5% CAGR and reach US$92 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Drug Safety Audits segment is readjusted to a revised 4.9% CAGR for the next 7-year period.

The U. S. Market is Estimated at $42.1 Million, While China is Forecast to Grow at 4.8% CAGR

The Pharmacovigilance and Drug Safety Software market in the U. S. is estimated at US$42.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$35.7 Million by the year 2027 trailing a CAGR of 4.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.9% and 4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Issue Tracking Segment to Record 5.4% CAGR

In the global Issue Tracking segment, USA, Canada, Japan, China and Europe will drive the 5.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$19.8 Million in the year 2020 will reach a projected size of US$28.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$23.3 Million by the year 2027. We bring years of research experience to this 6th edition of our report. The 181-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:
  • AB Cube
  • ArisGlobal LLC
  • Ennov USA
  • Extedo GmbH
  • Online Business Applications, Inc.
  • Oracle Corporation
  • Sarjen Systems Pvt. Ltd.
  • Sparta Systems, Inc.
  • United Biosource Corporation
Note: Product cover images may vary from those shown
2 of 2
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Global Competitor Market Shares
  • Pharmacovigilance and Drug Safety Software Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: Pharmacovigilance and Drug Safety Software Global Market Estimates and Forecasts in US$ by Region/Country: 2020-2027
  • TABLE 2: Pharmacovigilance and Drug Safety Software Market Share Shift across Key Geographies Worldwide: 2020 VS 2027
  • TABLE 3: ADR Reporting (Functionality) World Market by Region/Country in US$: 2020 to 2027
  • TABLE 4: ADR Reporting (Functionality) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027
  • TABLE 5: Drug Safety Audits (Functionality) Potential Growth Markets Worldwide in US$: 2020 to 2027
  • TABLE 6: Drug Safety Audits (Functionality) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027
  • TABLE 7: Issue Tracking (Functionality) Geographic Market Spread Worldwide in US$: 2020 to 2027
  • TABLE 8: Issue Tracking (Functionality) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
  • TABLE 9: Fully Integrated Software (Functionality) World Market Estimates and Forecasts by Region/Country in US$: 2020 to 2027
  • TABLE 10: Fully Integrated Software (Functionality) Market Share Breakdown by Region/Country: 2020 VS 2027
  • TABLE 11: Pharma & Biotech Companies (End-Use) Worldwide Latent Demand Forecasts in US$ by Region/Country: 2020-2027
  • TABLE 12: Pharma & Biotech Companies (End-Use) Distribution of Global Sales by Region/Country: 2020 VS 2027
  • TABLE 13: CROs (End-Use) Sales Estimates and Forecasts in US$ by Region/Country for the Years 2020 through 2027
  • TABLE 14: CROs (End-Use) Global Market Share Distribution by Region/Country for 2020 and 2027
  • TABLE 15: BPOs (End-Use) Global Opportunity Assessment in US$ by Region/Country: 2020-2027
  • TABLE 16: BPOs (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2020 VS 2027
  • TABLE 17: Other End-Uses (End-Use) Worldwide Sales in US$ by Region/Country: 2020-2027
  • TABLE 18: Other End-Uses (End-Use) Market Share Shift across Key Geographies: 2020 VS 2027
  • TABLE 19: On-premise (Deployment Model) Potential Growth Markets Worldwide in US$: 2020 to 2027
  • TABLE 20: On-premise (Deployment Model) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027
  • TABLE 21: On-demand (Deployment Model) Geographic Market Spread Worldwide in US$: 2020 to 2027
  • TABLE 22: On-demand (Deployment Model) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
  • Market Facts & Figures
  • US Pharmacovigilance and Drug Safety Software Market Share (in %) by Company: 2019 & 2025
  • Market Analytics
  • TABLE 23: United States Pharmacovigilance and Drug Safety Software Market Estimates and Projections in US$ by Functionality: 2020 to 2027
  • TABLE 24: United States Pharmacovigilance and Drug Safety Software Market Share Breakdown by Functionality: 2020 VS 2027
  • TABLE 25: United States Pharmacovigilance and Drug Safety Software Latent Demand Forecasts in US$ by End-Use: 2020 to 2027
  • TABLE 26: Pharmacovigilance and Drug Safety Software Market Share Breakdown in the United States by End-Use: 2020 VS 2027
  • TABLE 27: United States Pharmacovigilance and Drug Safety Software Market Estimates and Projections in US$ by Deployment Model: 2020 to 2027
  • TABLE 28: United States Pharmacovigilance and Drug Safety Software Market Share Breakdown by Deployment Model: 2020 VS 2027
CANADA
  • TABLE 29: Canadian Pharmacovigilance and Drug Safety Software Market Estimates and Forecasts in US$ by Functionality: 2020 to 2027
  • TABLE 30: Pharmacovigilance and Drug Safety Software Market in Canada: Percentage Share Breakdown of Sales by Functionality for 2020 and 2027
  • TABLE 31: Canadian Pharmacovigilance and Drug Safety Software Market Quantitative Demand Analysis in US$ by End-Use: 2020 to 2027
  • TABLE 32: Canadian Pharmacovigilance and Drug Safety Software Market Share Analysis by End-Use: 2020 VS 2027
  • TABLE 33: Canadian Pharmacovigilance and Drug Safety Software Market Estimates and Forecasts in US$ by Deployment Model: 2020 to 2027
  • TABLE 34: Pharmacovigilance and Drug Safety Software Market in Canada: Percentage Share Breakdown of Sales by Deployment Model for 2020 and 2027
JAPAN
  • TABLE 35: Japanese Market for Pharmacovigilance and Drug Safety Software: Annual Sales Estimates and Projections in US$ by Functionality for the Period 2020-2027
  • TABLE 36: Japanese Pharmacovigilance and Drug Safety Software Market Share Analysis by Functionality: 2020 VS 2027
  • TABLE 37: Japanese Demand Estimates and Forecasts for Pharmacovigilance and Drug Safety Software in US$ by End-Use: 2020 to 2027
  • TABLE 38: Pharmacovigilance and Drug Safety Software Market Share Shift in Japan by End-Use: 2020 VS 2027
  • TABLE 39: Japanese Market for Pharmacovigilance and Drug Safety Software: Annual Sales Estimates and Projections in US$ by Deployment Model for the Period 2020-2027
  • TABLE 40: Japanese Pharmacovigilance and Drug Safety Software Market Share Analysis by Deployment Model: 2020 VS 2027
CHINA
  • TABLE 41: Chinese Pharmacovigilance and Drug Safety Software Market Growth Prospects in US$ by Functionality for the Period 2020-2027
  • TABLE 42: Chinese Pharmacovigilance and Drug Safety Software Market by Functionality: Percentage Breakdown of Sales for 2020 and 2027
  • TABLE 43: Chinese Demand for Pharmacovigilance and Drug Safety Software in US$ by End-Use: 2020 to 2027
  • TABLE 44: Chinese Pharmacovigilance and Drug Safety Software Market Share Breakdown by End-Use: 2020 VS 2027
  • TABLE 45: Chinese Pharmacovigilance and Drug Safety Software Market Growth Prospects in US$ by Deployment Model for the Period 2020-2027
  • TABLE 46: Chinese Pharmacovigilance and Drug Safety Software Market by Deployment Model: Percentage Breakdown of Sales for 2020 and 2027
EUROPE
  • Market Facts & Figures
  • European Pharmacovigilance and Drug Safety Software Market: Competitor Market Share Scenario (in %) for 2019 & 2025
  • Market Analytics
  • TABLE 47: European Pharmacovigilance and Drug Safety Software Market Demand Scenario in US$ by Region/Country: 2018-2025
  • TABLE 48: European Pharmacovigilance and Drug Safety Software Market Share Shift by Region/Country: 2020 VS 2027
  • TABLE 49: European Pharmacovigilance and Drug Safety Software Market Estimates and Forecasts in US$ by Functionality: 2020-2027
  • TABLE 50: European Pharmacovigilance and Drug Safety Software Market Share Breakdown by Functionality: 2020 VS 2027
  • TABLE 51: European Pharmacovigilance and Drug Safety Software Addressable Market Opportunity in US$ by End-Use: 2020-2027
  • TABLE 52: European Pharmacovigilance and Drug Safety Software Market Share Analysis by End-Use: 2020 VS 2027
  • TABLE 53: European Pharmacovigilance and Drug Safety Software Market Estimates and Forecasts in US$ by Deployment Model: 2020-2027
  • TABLE 54: European Pharmacovigilance and Drug Safety Software Market Share Breakdown by Deployment Model: 2020 VS 2027
FRANCE
  • TABLE 55: Pharmacovigilance and Drug Safety Software Market in France by Functionality: Estimates and Projections in US$ for the Period 2020-2027
  • TABLE 56: French Pharmacovigilance and Drug Safety Software Market Share Analysis by Functionality: 2020 VS 2027
  • TABLE 57: Pharmacovigilance and Drug Safety Software Quantitative Demand Analysis in France in US$ by End-Use: 2020-2027
  • TABLE 58: French Pharmacovigilance and Drug Safety Software Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027
  • TABLE 59: Pharmacovigilance and Drug Safety Software Market in France by Deployment Model: Estimates and Projections in US$ for the Period 2020-2027
  • TABLE 60: French Pharmacovigilance and Drug Safety Software Market Share Analysis by Deployment Model: 2020 VS 2027
GERMANY
  • TABLE 61: Pharmacovigilance and Drug Safety Software Market in Germany: Recent Past, Current and Future Analysis in US$ by Functionality for the Period 2020-2027
  • TABLE 62: German Pharmacovigilance and Drug Safety Software Market Share Breakdown by Functionality: 2020 VS 2027
  • TABLE 63: Pharmacovigilance and Drug Safety Software Market in Germany: Annual Sales Estimates and Forecasts in US$ by End-Use for the Period 2020-2027
  • TABLE 64: Pharmacovigilance and Drug Safety Software Market Share Distribution in Germany by End-Use: 2020 VS 2027
  • TABLE 65: Pharmacovigilance and Drug Safety Software Market in Germany: Recent Past, Current and Future Analysis in US$ by Deployment Model for the Period 2020-2027
  • TABLE 66: German Pharmacovigilance and Drug Safety Software Market Share Breakdown by Deployment Model: 2020 VS 2027
ITALY
  • TABLE 67: Italian Pharmacovigilance and Drug Safety Software Market Growth Prospects in US$ by Functionality for the Period 2020-2027
  • TABLE 68: Italian Pharmacovigilance and Drug Safety Software Market by Functionality: Percentage Breakdown of Sales for 2020 and 2027
  • TABLE 69: Italian Demand for Pharmacovigilance and Drug Safety Software in US$ by End-Use: 2020 to 2027
  • TABLE 70: Italian Pharmacovigilance and Drug Safety Software Market Share Breakdown by End-Use: 2020 VS 2027
  • TABLE 71: Italian Pharmacovigilance and Drug Safety Software Market Growth Prospects in US$ by Deployment Model for the Period 2020-2027
  • TABLE 72: Italian Pharmacovigilance and Drug Safety Software Market by Deployment Model: Percentage Breakdown of Sales for 2020 and 2027
UNITED KINGDOM
  • TABLE 73: United Kingdom Market for Pharmacovigilance and Drug Safety Software: Annual Sales Estimates and Projections in US$ by Functionality for the Period 2020-2027
  • TABLE 74: United Kingdom Pharmacovigilance and Drug Safety Software Market Share Analysis by Functionality: 2020 VS 2027
  • TABLE 75: United Kingdom Demand Estimates and Forecasts for Pharmacovigilance and Drug Safety Software in US$ by End-Use: 2020 to 2027
  • TABLE 76: Pharmacovigilance and Drug Safety Software Market Share Shift in the United Kingdom by End-Use: 2020 VS 2027
  • TABLE 77: United Kingdom Market for Pharmacovigilance and Drug Safety Software: Annual Sales Estimates and Projections in US$ by Deployment Model for the Period 2020-2027
  • TABLE 78: United Kingdom Pharmacovigilance and Drug Safety Software Market Share Analysis by Deployment Model: 2020 VS 2027
REST OF EUROPE
  • TABLE 79: Rest of Europe Pharmacovigilance and Drug Safety Software Market Estimates and Forecasts in US$ by Functionality: 2020-2027
  • TABLE 80: Rest of Europe Pharmacovigilance and Drug Safety Software Market Share Breakdown by Functionality: 2020 VS 2027
  • TABLE 81: Rest of Europe Pharmacovigilance and Drug Safety Software Addressable Market Opportunity in US$ by End-Use: 2020-2027
  • TABLE 82: Rest of Europe Pharmacovigilance and Drug Safety Software Market Share Analysis by End-Use: 2020 VS 2027
  • TABLE 83: Rest of Europe Pharmacovigilance and Drug Safety Software Market Estimates and Forecasts in US$ by Deployment Model: 2020-2027
  • TABLE 84: Rest of Europe Pharmacovigilance and Drug Safety Software Market Share Breakdown by Deployment Model: 2020 VS 2027
ASIA-PACIFIC
  • TABLE 85: Pharmacovigilance and Drug Safety Software Market in Asia-Pacific by Functionality: Estimates and Projections in US$ for the Period 2020-2027
  • TABLE 86: Asia-Pacific Pharmacovigilance and Drug Safety Software Market Share Analysis by Functionality: 2020 VS 2027
  • TABLE 87: Pharmacovigilance and Drug Safety Software Quantitative Demand Analysis in Asia-Pacific in US$ by End-Use: 2020-2027
  • TABLE 88: Asia-Pacific Pharmacovigilance and Drug Safety Software Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027
  • TABLE 89: Pharmacovigilance and Drug Safety Software Market in Asia-Pacific by Deployment Model: Estimates and Projections in US$ for the Period 2020-2027
  • TABLE 90: Asia-Pacific Pharmacovigilance and Drug Safety Software Market Share Analysis by Deployment Model: 2020 VS 2027
REST OF WORLD
  • TABLE 91: Rest of World Pharmacovigilance and Drug Safety Software Market Estimates and Forecasts in US$ by Functionality: 2020 to 2027
  • TABLE 92: Pharmacovigilance and Drug Safety Software Market in Rest of World: Percentage Share Breakdown of Sales by Functionality for 2020 and 2027
  • TABLE 93: Rest of World Pharmacovigilance and Drug Safety Software Market Quantitative Demand Analysis in US$ by End-Use: 2020 to 2027
  • TABLE 94: Rest of World Pharmacovigilance and Drug Safety Software Market Share Analysis by End-Use: 2020 VS 2027
  • TABLE 95: Rest of World Pharmacovigilance and Drug Safety Software Market Estimates and Forecasts in US$ by Deployment Model: 2020 to 2027
  • TABLE 96: Pharmacovigilance and Drug Safety Software Market in Rest of World: Percentage Share Breakdown of Sales by Deployment Model for 2020 and 2027
IV. COMPETITION
  • Total Companies Profiled: 47
Note: Product cover images may vary from those shown
Adroll
adroll